Publicacións nas que colabora con Vicenta Martínez Zorzano (16)

2022

  1. Evaluation of Blood Soluble CD26 as a Complementary Biomarker for Colorectal Cancer Screening Programs

    Cancers, Vol. 14, Núm. 19

2018

  1. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples

    Clinical Epigenetics, Vol. 10, Núm. 1

  2. Proteomic profiling for colorectal cancer biomarker discovery

    Methods in Molecular Biology (Humana Press Inc.), pp. 241-269

2016

  1. Evaluation of serum nucleoside diphosphate kinase A for the detection of colorectal cancer

    Scientific Reports, Vol. 6

2015

  1. Serum matrix metalloproteinase-9 in colorectal cancer family-risk population screening

    Scientific Reports, Vol. 5

  2. Serum sCD26 for colorectal cancer screening in family-risk individuals: Comparison with faecal immunochemical test

    British Journal of Cancer, Vol. 112, Núm. 2, pp. 375-381

2014

  1. Niveles séricos de metalopretasa-9 en individuos con riesgo familiar de cáncer colorrectal

    Investigación: cultura, ciencia y tecnología, Núm. 11, pp. 8-13

2004

  1. Clinical significance of preoperative serum sialic acid levels in colorectal cancer: Utility in the detection of patients at high risk of tumor recurrence

    International Journal of Biological Markers, Vol. 19, Núm. 1, pp. 38-45

2003

  1. Combined use of established and novel tumour markers in the diagnosis of head and neck squamous cell carcinoma

    Oncology Reports, Vol. 10, Núm. 5, pp. 1345-1350

  2. Purification of human alpha-L-fucosidase precursor expressed in Escherichia coli as a glutathione S-transferase fusion protein

    Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, Vol. 786, Núm. 1-2, pp. 7-15

2002

  1. Lectin isolation and detection of N-glycoproteins bearing sialic acid and L-fucose residues in human colorectal mucosa and in adenocarcinoma biopsies.

    International journal of oncology, Vol. 20, Núm. 2, pp. 367-372

2001

  1. Cell surface human α-L-fucosidase

    European Journal of Biochemistry, Vol. 268, Núm. 11, pp. 3321-3331

2000

  1. Immunohistochemical analysis of sialic acid and fucose composition in human colorectal adenocarcinoma

    Tumor Biology, Vol. 21, Núm. 3, pp. 153-164

  2. Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer

    Oncology, Vol. 59, Núm. 4, pp. 310-316

  3. α-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence

    Cancer Detection and Prevention, Vol. 24, Núm. 2, pp. 143-149

1996

  1. Low levels of α-L-fucosidase activity in colorectal cancer are due to decreased amounts of the enzymatic protein and are related with Dukes' stage

    International Journal of Oncology, Vol. 9, Núm. 4, pp. 747-754